Certified by Founder Lodge
Ability Biologics
Canada - Montreal, Quebec
START UP
1 Disclosed Funding Rounds $12,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our Mission:
Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
The premier biotherapeutic tar
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 07 ,2023 | Seed | $12,000,000 | |
| June, 19 ,2024 | Seed | $18,000,000.00 |
Alexandria Real Estate Equities, Inc.
Charles River Laboratories
Amplitude Ventures
Fonds de solidarité FTQ
Page One Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
